Epigral Ltd (EPIGRAL)
₹1660.1▲12.81%
🔔 Financial Results Alert
Epigral Ltd's Q1FY25 net profit and revenue grew by 169% and 43% YoY respectively, shares gained up to 17%
Analyst Rating
based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts offering long term price targets for Epigral Ltd. An average target of ₹2000
Source: S&P Global Market Intelligence
Epigral Ltd Share analysis
Source: S&P Global Market Intelligence
Performance
Day's Low
Day's High
₹1,481.1₹1,72452 Week's Low
52 Week's High
₹862.05₹1,724
| Returns % | |
| 1 Month Return | + 8.73 % |
| 3 Month Return | + 9.36 % |
| 1 Year Return | + 54.85 % |
| Market Stats | |
| Previous Close | ₹1,471.65 |
| Open | ₹1,481.95 |
| Volume | 11.47L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹6,114.73Cr |
Key Statistics
| P/E Ratio | 31.23 |
| PEG Ratio | -0.82 |
| Market Cap | ₹6,114.73 Cr |
| P/B Ratio | 3.63 |
| EPS | 60.84 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹6,114.73 Cr | 52.41% | 0.71 | ₹195 Cr | ₹1,929 Cr |
 | NA | ₹933.17 Cr | -11.29% | 0.56 | NA | NA |
 | NA | ₹252.28 Cr | 6.32% | 0.54 | NA | NA |
 | NA | ₹596.80 Cr | 175.63% | 0.63 | NA | NA |
 | NA | ₹18.42 Cr | 11.96% | 2.12 | NA | NA |
Mutual Fund Holdings
Company Information
Share Price: ₹1660.10 per share as on 24 Jul, 2024 04:01 PM
Market Capitalisation: ₹6,114.73Cr as of today
Revenue: ₹524.63Cr as on March 2024 (Q1 24)
Net Profit: ₹77.28Cr as on March 2024 (Q1 24)
Listing date: 18 Aug, 2021
Chairperson Name: Maulik Jayantibhai Patel
| Organisation | Epigral Ltd |
| Headquarters | Ahmedabad |
| Industry | Chemicals |
| E-voting on shares | Click here to vote |
What's happening today
Today's Timeline - Invalid Date
03:55 PM
-Epigral Ltd shares surge up to 17% after Q1FY25 net profit and revenue magnify by 169% and 43% YoY, respectively.
07:09 PM
-Epigral's PAT jumps over two-fold to Rs 86 crore in Q1FY25; revenue from operations logs 43% growth YoY at Rs 651 crore.
Key events for Epigral Ltd
Epigral Shares Surge on Strong Q1FY25 Results - 24 Jul, 2024
Integrated chemicals manufacturer Epigral Ltd reports a significant increase in net profit and revenue for Q1FY25, resulting in a surge of up to 17% in share prices. The company attributes the growth to higher capacity utilization, commissioning of new projects, and efficient utilization of capacities.
Emkay Global Initiates Coverage on Epigral Ltd with Buy Rating - 05 Jul, 2024
Emkay Global has initiated coverage on Epigral Ltd with a buy rating and sets a twelve-month target price of Rs 2000 per share, significantly above its current market price. They anticipate consistent earnings growth driven by higher capacity utilization, expanding into chlorine derivatives and value-added products, and scaling up existing and new chemistries. The company expects to generate robust operating cash flows exceeding Rs1600 crore from FY25 to FY27E.
Epigral Stock Price Surges; Emkay Initiates Coverage with Buy Rating - 04 Jul, 2024
Epigral Ltd's stock price has surged by 29% in a month and 49% in the last year. Emkay Global Financials initiates coverage on Epigral with a BUY rating and target price of Rs2,000/sh.
Emkay Global Initiates Coverage on Epigral with Target Price of Rs 2,000 - 02 Jul, 2024
Emkay Global has initiated coverage on Epigral with a target price of Rs 2,000. The company is expected to benefit from the bottoming out of the caustic soda cycle and an increase in chlorine derivatives contribution. Earnings are projected to consistently grow at a rate of 25%+ CAGR with healthy return ratios.
Epigral Ltd's Share Price Rises by 9.3% After Commissioning New Manufacturing Plant - 01 Jul, 2024
Epigral Ltd's share price rose by 9.3% after the successful commissioning of a new manufacturing plant in Gujarat for Chlorinated Polyvinyl Chloride (CPVC) production. The company reported an 11.8% decline in revenues and a 44.7% decrease in net profits YoY, but generated an overall return of 36.38% over the past year.
Insights on Epigral Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPromoter Holding Up
Promoters have increased holdings from 71.49% to 71.58% in Jun 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 473.98 Cr → 526.77 Cr (in ₹), with an average increase of 10.0% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 1.36% to 1.47% in Jun 2024 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 0.02% to 0.05% in Jun 2024 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, 31.51 Cr → 77.28 Cr (in ₹), with an average increase of 25.4% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, EPIGRAL stock has moved up by 2.4%
NO EFFECTAgainst Peers
In the last 1 year, Solar Industries India Ltd has given 184.8% return, outperforming this stock by 130.0%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 27.10% to 26.74% in Jun 2024 quarter
Company Financials
| Q'1 24 | Q/Q Change | |
|---|---|---|
Revenue | ₹524.63Cr | ↑11.26% |
Net Income | ₹77.28Cr | ↑57.46% |
Net Profit Margin | 14.73% | ↑41.50% |
| 2024 | Y/Y Change | |
|---|---|---|
Revenue | ₹1,929.19Cr | ↓11.84% |
Net Income | ₹195.87Cr | ↓44.56% |
Net Profit Margin | 10.15% | ↓37.11% |
| 2024 | Y/Y Change | |
|---|---|---|
Total Assets | ₹2,794.34Cr | ↑14.89% |
Total Liabilities | ₹1,485.25Cr | ↑18.53% |
| 2024 | Y/Y Change | |
|---|---|---|
Operating Cash Flow | ₹397.69Cr | ↓36.49% |
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 71.58% | 0.14 | |
| Foreign Institutions | 1.47% | 7.72 | |
| Mutual Funds | 0.05% | 122.37 | |
| Retail Investors | 26.74% | ||
| Others | 0.15% | 515.60 |
Key Indicators
Epigral Ltd Valuation
Epigral Ltd in the last 5 years
Lowest (9.04x)
March 28, 2023
Today (31.23x)
July 23, 2024
Industry (46.52x)
July 23, 2024
Highest (33.11x)
July 3, 2024
Earnings and Dividends
Epigral Ltd Earnings Results
Epigral Ltd’s net profit jumped 0.72% since last year same period to ₹77.28Cr in the Q4 2023-2024. On a quarterly growth basis, Epigral Ltd has generated 57.46% jump in its net profits since last 3-months.
Read More about Earnings ResultsEpigral Ltd Dividends April,2024
In the quarter ending March 2024, Epigral Ltd has declared dividend of ₹5 - translating a dividend yield of 0.51%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Epigral Ltd is currently in a Bullish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Epigral Ltd shares.
Epigral Ltd (EPIGRAL) share price today is ₹1660.1
Epigral Ltd is listed on NSE
Epigral Ltd is listed on BSE
- Today’s highest price of Epigral Ltd is ₹1724.
- Today’s lowest price of Epigral Ltd is ₹1481.1.
PE Ratio of Epigral Ltd is 31.23
PE ratio = Epigral Ltd Market price per share / Epigral Ltd Earnings per share
Today’s traded volume of Epigral Ltd(EPIGRAL) is 11.47L.
Today’s market capitalisation of Epigral Ltd(EPIGRAL) is ₹6114.73Cr.
| Epigral Ltd(EPIGRAL | Price |
|---|---|
52 Week High | ₹1724 |
52 Week Low | ₹862.05 |
Epigral Ltd(EPIGRAL) share price is ₹1660.1. It is down -3.71% from its 52 Week High price of ₹1724
Epigral Ltd(EPIGRAL) share price is ₹1660.1. It is up 92.58% from its 52 Week Low price of ₹862.05
| Epigral Ltd(EPIGRAL | Returns |
|---|---|
1 Day Returns | 188.45% |
1 Month Returns | 8.73% |
3 Month Returns | 9.36% |
1 Year Returns | 54.85% |